Synchronous Tonsil, Gallbladder, and Cardiac Metastases without any other Visceral Metastases of Malignant Melanoma

2009 ◽  
Vol 32 (4) ◽  
pp. 197-199 ◽  
Author(s):  
Irfan Cicin ◽  
Ufuk Usta ◽  
Atakan Sezer ◽  
Suat Canbaz ◽  
Sernaz Uzunoglu ◽  
...  
2007 ◽  
Vol 30 (7) ◽  
pp. 359-360 ◽  
Author(s):  
Kian Keong Poh ◽  
Erick Avelar ◽  
Lanqi Hua ◽  
Mary Etta King

2017 ◽  
Vol 17 (1) ◽  
Author(s):  
Tanja Zitzelsberger ◽  
Thomas K. Eigentler ◽  
Patrick Krumm ◽  
Konstantin Nikolaou ◽  
Claus Garbe ◽  
...  

Cancer ◽  
1999 ◽  
Vol 85 (1) ◽  
pp. 78-84 ◽  
Author(s):  
Peter Gibbs ◽  
Jonathan S. Cebon ◽  
Paul Calafiore ◽  
William A. Robinson

2015 ◽  
Vol 3 (2) ◽  
Author(s):  
Maryam Moshkani Farahani ◽  
Neda Raeessi

Pteridines ◽  
1989 ◽  
Vol 1 (1) ◽  
pp. 19-21 ◽  
Author(s):  
P. Mura ◽  
M. Barriere ◽  
Y. Papet ◽  
D. Reiss ◽  
I. Camenen ◽  
...  

Summary Serial urinary neopterin determinations were performed in 151 patients after exeresis of a malignant melanoma. Values for patients clinically free of disease at the end of the observation were similar to those of healthy subjects. No significant varia tions were observed in patients with cutaneous meta stases. The most important variations were found in patients who developed ganglionic and above all visceral metastases. These data suggest that neopterin determination could be very useful in the follow-up of patients with a malignant melanoma and especially for detecting visceral metastases occurences.


2004 ◽  
Vol 14 (4) ◽  
pp. A18 ◽  
Author(s):  
T. Bischiniotis ◽  
C. Andreadis ◽  
C. Zavos ◽  
N. Diamantopoulos ◽  
P. Georgiou ◽  
...  

Author(s):  
D CHRISSOS ◽  
P STOUGIANNOS ◽  
D MYTAS ◽  
A KATSAROS ◽  
G ANDRIKOPOULOS ◽  
...  

Author(s):  
Claudine Piérard-Franchimont ◽  
Trinh Hermanns-Lê ◽  
Philippe Delvenne ◽  
Gérald E. Piérard

The presentations of primary and metastatic cutaneous malignant melanoma (CMM) are very diverse. Evidence increasingly indicates that single CMM cells spread to distant sites quite early during cancer progression and are soon eliminated before they become clinically detectable. However bulky metastases which appear at a later stage might derive from some of these early neoplastic cells. It seems that local CMM single cell micro-metastases commonly predict sentinel lymph node involvement without overtly reflecting CMM progression to bulky visceral metastases. This study is intended to review the current understanding of the mechanisms underlying two CMM presentations. The first is the long interval, apparently disease-free, with persistent CMM dormancy, which may precede overt metastatic growth. Immunosurveillance may induce dormancy in single CMM cells disseminated in the body by blocking their proliferation cycle. The second is the socalled CMM smoldering phenomenon, which is marked by an alternate progression and regression of CMM locally with metastases that wax and wane for long periods of time over restricted skin areas. These very diverse patterns of CMM progression are likely to be ascribable to a number of biological factors, including the activation of CMM stem cells, and the combined phenotypic heterogeneity and variability in proliferative amplification in CMM cell clusters. Furthermore an adequate stimulation of CMM immune-surveillance and the induction of a specific stromal structure and vascular response are required. In this context, most early CMM tumors are in part controlled by lymphocytemediated responses before they become clinically detectable. However both the role of immune-surveillance and the mechanisms underlying both persistent and smoldering CMM dormancy remain unclear.


Sign in / Sign up

Export Citation Format

Share Document